Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Max IndiaNSE:MAXIND -1.21%66 EV-to-EBITDA is -8.93 as of Sep. 02, 2026. GuruFocus rates NSE:MAXIND with a GF Score™ of 66/100 and a GF Value™ of ₹225.14 (Possible Value Trap). The stock has 3 warning signs investors should review. Among 515 Healthcare Providers & Services companies, Max India ranks worse than 194174.56% on this metric.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Max India's enterprise value is ₹8,236 Mil.
Max India's EBITDA for the trailing twelve months (TTM) ended in Jun. 2026 was ₹-922 Mil. Therefore, Max India's EV-to-EBITDA for today is -8.93.
The historical rank and industry rank for Max India's EV-to-EBITDA or its related term are showing as below:
NSE:MAXIND'
s EV-to-EBITDA Range Over the Past 10 Years
Min: -2709.9 Med: -8.99 Max: 218.18
Current: -8.93
During the past 10 years, the highest EV-to-EBITDA of Max India was 218.18. The lowest was -2709.90. And the median was -8.99.
NSE:MAXIND's EV-to-EBITDA is ranked worse than 100% of 515
companies
in the Healthcare Providers & Services industry
Industry Median: 10.43
vs NSE:MAXIND: -8.93
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Max India's share price for today is ₹148.97.
Max India's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹-25.270.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
The historical data trend for Max India's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:MAXIND vs HCA, THC, EHC: EV-to-EBITDA Comparison
For the Medical Care Facilities subindustry, Max India's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Max India EV-to-EBITDA vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Max India's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Max India's EV-to-EBITDA falls into.
Max India's current Enterprise Value is ₹8,236 Mil.
Max India's EBITDA for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹-922 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Max India (NSE:MAXIND) has a EV-to-EBITDA of -8.93 as of Sep. 02, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Max India. According to the industry distribution chart, Max India ranks #999999 out of 515 companies in the Healthcare Providers & Services industry.
Is Max India's EV-to-EBITDA too high?
Max India's current EV-to-EBITDA is -8.93. Based on the distribution chart, Max India ranks #999999 out of 515 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Max India has a GF Score™ of 66/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Max India's EV-to-EBITDA compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Max India ranks #999999 out of 515 companies for EV-to-EBITDA. This places Max India in the lower half of its industry. The industry median EV-to-EBITDA is 10.43. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Healthcare Providers & Services company?
The median EV-to-EBITDA among Healthcare Providers & Services companies is 10.43, based on 515 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Max India. For the Healthcare Providers & Services industry, the median EV-to-EBITDA is 10.43 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Max India's current EV-to-EBITDA is -8.93. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Max India stock overvalued right now?
Based on GuruFocus' analysis, Max India (NSE:MAXIND) is currently considered Possible Value Trap. The stock's GF Value™ is ₹225.14, compared to a current price of ₹148.97 — trading 33.8% below its estimated fair value. The current EV-to-EBITDA is -8.93. Max India's overall GF Score™ is 66/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For Max India (NSE:MAXIND), the current EV-to-EBITDA is -8.93 as of Sep. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Max India (NSE:MAXIND) Overvalued in 2026?
Based on GuruFocus' analysis, Max India stock appears to be undervalued.
The current stock price of ₹148.97 is trading 33.8% below its estimated GF Value™ of ₹225.14.
GuruFocus considers Max India to be Possible Value Trap.
Key valuation signals for NSE:MAXIND:
EV-to-EBITDA: -8.93
GF Value™: ₹225.14 vs. price of ₹148.97 (33.8% below fair value)
No single metric tells the full story. See the NSE:MAXIND stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Max India Ltd is a multi-business corporate that operates in the healthcare sector. The company provides healthcare services. Also, the company provides health insurance policies, senior-living communities, and other health-related training services. The business operates in four segments namely, Business Investments, Senior Living, Assisted Care, and Other. It derives maximum revenue from Senior Living segment.
66GF Score
Get the complete analysis for NSE:MAXIND
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:MAXIND has been successfully added to your 
